Lenskart co-founder Peyush Bansal revealed the company has conducted 5.5 million AI-assisted eye tests, marking a significant scale milestone for computer vision in healthcare. The Indian eyewear giant currently uses AI algorithms to guide remote eye examinations, where specialists still oversee the process but AI handles much of the diagnostic workflow.
This represents one of the largest deployments of AI-powered medical testing outside traditional healthcare systems. While tech companies have dabbled in health AI, Lenskart's scale demonstrates how vertical-specific AI can create real business value when deployed systematically. The 5.5 million test figure puts them ahead of many dedicated health-tech startups in terms of actual patient interactions processed through AI systems.
However, Bansal's bigger claim about "AI-based self-testing" — where algorithms would handle examinations without human specialists — remains largely promotional. The company admits this capability is still in "early stages," suggesting their current 5.5 million tests still require human oversight. This gap between current AI-assisted operations and promised autonomous testing reflects a common pattern: companies scaling AI successfully in constrained domains while overpromising on full automation.
For developers building healthcare AI, Lenskart's approach offers a practical template: start with AI augmentation rather than replacement, achieve massive scale with human-in-the-loop systems, then gradually increase automation. Their infrastructure likely handles computer vision, workflow orchestration, and specialist routing — a more complex but proven path than attempting fully autonomous medical AI from day one.